[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341444-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341444-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-mimicry-of-sars-cov-2-antigens-as-a-possible-natural-anti-cancer-preventive-immunization","Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization","","Investigates whether peptides spanning the full SARS-CoV-2 proteome share sequence homology with tumor-associated antigens (TAAs) and can elicit cross-reactive CD8+ T cells after either BNT162b2 vaccination or natural infection. Predicted viral epitopes with high affinity (\u003C100 nM) for HLA-A*02:01 were mapped for shared and variant-specific targets. Homology was observed across viral proteins, especially Orf1ab and Spike, matching multiple TAAs linked to breast, liver, melanoma, and colon cancers. Structural similarities and cross-reactive CD8+ T cell clones were identified.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-mimicry-of-sars-cov-2-antigens-as-a-possible-natural-anti-cancer-preventive-immunization/341444/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-mimicry-of-sars-cov-2-antigens-as-a-possible-natural-anti-cancer-preventive-immunization/341444.png","ImageObject",300,407,{"name":42,"@type":43},"Noah","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the study test regarding SARS-CoV-2 and cancer?","Question",{"text":63,"@type":64},"It tests whether SARS-CoV-2–derived peptides share homology with tumor-associated antigens (TAAs) and whether cross-reactive CD8+ T cells can be elicited after BNT162b2 vaccination or natural infection.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which viral regions and cancer-related TAAs show the strongest molecular mimicry?",{"text":68,"@type":64},"Homology is reported across all viral proteins, mainly Orf1ab and Spike, and the matched TAAs are associated with breast, liver, melanoma, and colon cancers.",{"name":70,"@type":61,"acceptedAnswer":71},"How were cross-reactive T cells identified in the study?",{"text":72,"@type":64},"Predicted epitopes were used to detect cross-reactive CD8+ T cell clones, reported as found by MHC class I dextramer staining with paired peptides.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341444,1790161555,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","TYPE Original Research PUBLISHED 14 June 2024  \nDOI 10.3389/fimmu.2024.1398002  \nOPEN ACCESS  \nEDITED BY  \nFrancesco Cappello, University of Palermo, Italy  \nREVIEWED BY  \nGiuseppe Maccari,  \nThe Pirbright Institute, United Kingdom Katherine Wendy Cook,  \nScancell Ltd, United Kingdom  \n*CORRESPONDENCE Maria Tagliamonte  \n [m.tagliamonte@istitutotumori. na.it](m.tagliamonte@istitutotumori. na.it)[ ](m.tagliamonte@istitutotumori. na.it)Luigi Buonaguro  \n l. buonaguro@istitutotumori. na. it  \n†These authors have contributed equally to this work  \nRECEIVED 08 March 2024  \nACCEPTED 20 May 2024  \nPUBLISHED 14 June 2024  \nCITATION  \nRagone C, Mauriello A, Cavalluzzo B, Cavalcanti E, Russo L, Manolio C, Mangano S, Cembrola B, Tagliamonte M and Buonaguro L (2024) Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization.  \nFront. Immunol. 15:1398002 .  \ndoi: 10.3389/fimmu.2024.1398002  \nCOPYRIGHT  \n© 2024 Ragone, Mauriello, Cavalluzzo, Cavalcanti, Russo, Manolio, Mangano, Cembrola, Tagliamonte and Buonaguro. This isan open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMolecular mimicry of SARSCOV-2 antigens as a possible natural anti-cancer preventive immunization  \nConcetta Ragone 1†, Angela Mauriello 1†, Beatrice Cavalluzzo 1, Ernesta Cavalcanti 2, Luigi Russo 2, Carmen Manolio 3, Simona Mangano 1, Biancamaria Cembrola 1,  \nMaria Tagliamonte 1* and Luigi Buonaguro 1*  \n1 Innovative Immunological Models Unit, Istituto Nazionale Tumori -IRCCS- “Fond G. Pascale”, Naples, Italy, 2 Lab of Clinical Pathology, Istituto Nazionale Tumori -IRCCS- “ Fond G. Pascale”, Naples, Italy, 3Clinical and Epidemiological Genetics Unit, Azienda Ospedaliera – University of Padua, Padua, Italy  \nBackground: In the present study we investigated whether peptides derived from the entire SARS-CoV-2 proteome share homology to TAAs (tumor-associated antigens) and cross-reactive CD8+ T cell can be elicited by the BNT162b2 preventive vaccine or the SARS-CoV-2 natural infection.  \nMethods and results: Viral epitopes with high afﬁnity (\u003C100nM) to the HLAA*02:01 allele were predicted. Shared and variant-speciﬁc epitopes were identiﬁed. Signiﬁcant homologies in amino acidic sequence have been found between SARS-CoV-2 peptides and multiple TAAs, mainly associated with breast, liver, melanoma and colon cancers. The molecular mimicry of the viral epitopes and the TAAs was found in all viral proteins, mostly the Orf 1ab and the Spike, which is included in the BNT162b2 vaccine. Predicted structural similarities conﬁrmed the sequence homology and comparable patterns of contact with both HLA and TCR a and b chains were observed. CD8+ T cell clones cross-reactive with the paired peptides have been found by MHC class l-dextramer staining.  \nConclusions: Our results show for the ﬁrst time that several SARS-COV-2 antigens are highly homologous to TAAs and cross-reactive T cells are identiﬁed in infected and BNT162b2 preventive vaccinated individuals. The implication would be that the SARS-Cov-2 pandemic could represent a natural preventive immunization for breast, liver, melanoma and colon cancers. In the coming years, real-world evidences will provide the ﬁnal proof for such immunological experimental evidence. Moreover, such SARS-CoV-2 epitopes can be used to develop “multicancer” off-the-shelf preventive/therapeutic vaccine formulations, with higher antigenicity and immunogenicity than over-expressed tumor self-antigens, for the potential valuable beneﬁt of thousands of cancer patients around the World.  \nKEYWORDS  \nSARS-CoV-2,(TAA) tumor-associated anti","cbCaiuIp9q1tCsXM","https://ap.wps.com/l/cbCaiuIp9q1tCsXM","pdf",12844311,21,"English","# 1 Introduction\n## COVID-19 pandemic and vaccine context\n## BNT162b2 and Spike/ACE2 mechanism\n## T-cell reactivity after vaccination and infection","[{\"question\":\"What does the study test regarding SARS-CoV-2 and cancer?\",\"answer\":\"It tests whether SARS-CoV-2–derived peptides share homology with tumor-associated antigens (TAAs) and whether cross-reactive CD8+ T cells can be elicited after BNT162b2 vaccination or natural infection.\"},{\"question\":\"Which viral regions and cancer-related TAAs show the strongest molecular mimicry?\",\"answer\":\"Homology is reported across all viral proteins, mainly Orf1ab and Spike, and the matched TAAs are associated with breast, liver, melanoma, and colon cancers.\"},{\"question\":\"How were cross-reactive T cells identified in the study?\",\"answer\":\"Predicted epitopes were used to detect cross-reactive CD8+ T cell clones, reported as found by MHC class I dextramer staining with paired peptides.\"}]","Molecular mimicry of SARS-COV-2 antigens as a possible natural anti-cancer preventive immunization | PDF",1790041908,53,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2558aae8ab98e4b6d2f403b937b50cec.webp",983,1389,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c236263108b1360d576212c38cb6c25e.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1e819a26f5945df630e3f0b882273643.webp",981,1386,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ea54c39abcb4b2d3a5f9ed8e65b56e61.webp",980,1385]